Skip to content
10-Q

Quarterly Report

KEDEM PHARMACEUTICALS INC.

0001493152-11-000394

← back to feed
Filed
Oct 18, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · Oct 17, 2011 206.33M sh
Operating Cash Flow Q1 2012 · Aug 31, 2011 −$3.24M
Operating Cash Flow Q1 2012 · Aug 31, 2010 −$299.87K
Stockholders Equity Q1 2012 · Aug 31, 2011 $98.65K
Stockholders Equity Q1 2012 · May 31, 2010 $1.07M
Current Liabilities Q1 2012 · Aug 31, 2011 $2.96M
Current Liabilities Q1 2012 · May 31, 2011 $2.13M
Current Assets Q1 2012 · Aug 31, 2011 $1.6M
Current Assets Q1 2012 · May 31, 2011 $1.53M
Total Assets Q1 2012 · Aug 31, 2011 $3.06M
Total Assets Q1 2012 · May 31, 2011 $2.71M
Sga Expense Q1 2012 · Aug 31, 2011 $699.07K
Sga Expense Q1 2012 · Aug 31, 2010 $50.12K
Rd Expense Q1 2012 · Aug 31, 2011 $1.53M
Rd Expense Q1 2012 · Aug 31, 2010 $155.45K
Net Income Q1 2012 · Aug 31, 2011 −$8.06M
Net Income Q1 2012 · Aug 31, 2010 −$625.29K
Operating Income Q1 2012 · Aug 31, 2011 −$4.88M
Operating Income Q1 2012 · Aug 31, 2010 −$507.01K
Cash And Equivalents Q1 2012 · Aug 31, 2010 $741.42K
Cash And Equivalents Q1 2012 · May 31, 2010 $1.05M